Real life experiences in HCV management in 2018
- 30 December 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 17 (2) , 117-128
Abstract
Introduction: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Treatment of chronic hepatitis C has considerably improved in the last few years thanks to the introduction of direct acting antivirals able to achieve sustained virological response in more than 95% of patients. Successful anti-HCV treatment can halt liver disease progression and solve the HCV-related extra-hepatic manifestations, eventually reducing liver-related and overall mortality. Areas covered: With the aim to respond to unmet needs in patient’s identification, universal access to antiviral therapy and treatment optimization in specific setting of HCV-infected patients, a group of Italian experts met in Stresa in May 2018. The summary of the considerations arising from this meeting and the final statements are reported in this paper. Expert commentary: All the advances on HCV cure may have a real clinical impact not only in individual patients but also at the social health level if they are applied to all infected patients, independently from the stage of liver disease. Further improvements are needed in order to attain HCV elimination, such as the development of an enhanced screening program working in parallel to the present treatment options.Keywords
Funding Information
- funded by an unrestricted grant from Gilead Sciences
This publication has 72 references indexed in Scilit:
- Recommendations for the management of hepatitis C virus infection among people who inject drugsInternational Journal of Drug Policy, 2015
- Dried Blood Spots: A Tool to Ensure Broad Access to Hepatitis C Screening, Diagnosis, and Treatment MonitoringThe Journal of Infectious Diseases, 2015
- The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM)Current Opinion in HIV and AIDS, 2015
- Cost‐effectiveness of strategies for testing current hepatitis C virus infectionHepatology, 2015
- Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-AnalysisPLOS ONE, 2015
- Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2013
- Sexually transmitted hepatitis C infectionCurrent Opinion in Infectious Diseases, 2013
- Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis CAnnals of Internal Medicine, 2012
- Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference #Hepatology, 2009
- Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus–coinfected patients†‡Hepatology, 2006